Assessment of Insulin Sensitivity and Insulin Secretion From the Oral Glucose Tolerance Test in Nonobese Japanese Type 2 Diabetic Patients: Comparison With Minimal-Model Approach

Diabetes Care - United States
doi 10.2337/diacare.23.9.1439
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

Insulin Tolerance Test Predicts the Effectiveness of Insulin Sensitizers in Japanese Type 2 Diabetic Patients

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2010English

Optimization of Insulin Sensitivity and Glucose Effectiveness Index From an Oral Glucose Tolerance Test Using Modified Oral Minimal Model and Gravitational Search Algorithm

Applied Mathematical Sciences
2017English

Long-Term Follow-Up of Oral Glucose Tolerance Test-Derived Glucose Tolerance and Insulin Secretion and Insulin Sensitivity Indexes in Subjects With Glucokinase Mutations (MODY2)

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2008English

Insulin Release in Impaired Glucose Tolerance: Oral Minimal Model Predicts Normal Sensitivity to Glucose but Defective Response Times

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2002English

Assessment of Insulin Sensitivity From Plasma Insulin and Glucose in the Fasting or Post Oral Glucose-Load State

Reproduction Nutrition Development
1998English

Comparison of Glucose Tolerance Test in AMHTS and Re-Examination, With Special Reference to Insulin Secretion

Japanese journal of MHTS
1988English

Comparison of Effect of Pioglitazone With Metformin or Sulfonylurea (Monotherapy and Combination Therapy) on Postload Glycemia and Composite Insulin Sensitivity Index During an Oral Glucose Tolerance Test in Patients With Type 2 Diabetes

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2005English

Effects of Telmisartan on Insulin Resistance in Japanese Type 2 Diabetic Patients

Internal Medicine
Internal MedicineMedicine
2010English

Sodium-Glucose Cotransporter 2 Inhibitors Reduce Prandial Insulin Doses in Type 2 Diabetic Patients Treated With the Intensive Insulin Therapy

Journal of Clinical Medicine Research
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy